Glass House Brands (GLAS) Buildings (2021 - 2024)

Glass House Brands (GLAS) posted quarterly Buildings of $154.2 million for Q1 2024, up 7.67% quarter-over-quarter from $143.2 million in Q4 2023.

Glass House Brands (GLAS) Buildings (2021 - 2024) Analysis & Trends

Glass House Brands (GLAS) has reported Buildings for 4 consecutive years, with $154.2 million the latest figure, recorded in Q1 2024.

In Q1 2024, Buildings changed N/A year-over-year to $154.2 million; the TTM figure through Mar 2024 stood at $154.2 million (changed N/A YoY), while the FY2023 annual figure was $143.2 million, changed N/A from the prior year.
Buildings rose to $154.2 million in Q1 2024 per GLAS's latest filing, from $143.2 million in the prior quarter.
Across five years, Buildings topped out at $154.2 million in Q1 2024 and bottomed at $108.0 million in Q4 2021.
Historically, Buildings has averaged $128.4 million across 4 years, with a median of $125.6 million in 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Glass House Brands	830.21 Mn	811.66 Mn	15.77 Mn

Download Data